Tycho Peterson, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 140,000 shares at $8.53 ($1.2M) on 2023-06-15, disclosed to the SEC on 2023-06-20.
Scheduled sale ($1.2M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.53 | 14,328 | $122K | 10.2% |
| 2 | $8.53 | 14,328 | $122K | 10.2% |
| 3 | $8.53 | 55,672 | $475K | 39.8% |
| 4 | $8.53 | 55,672 | $475K | 39.8% |
| Total | $8.53 avg | 140,000 | $1.2M | 100% |
| Filing → |
| ADPT | SELL | 2023-06-06 | $272K | — | Filing → |